The DOVE device is an auto-injector that can detect an overdose as it occurs and inject naloxone in a timely manner to reverse the fatal overdose.It will be capable of preventing the overdose deaths that occur when patients are alone. This will also help save insurers and governments from hospitalization costs of overdoses where naloxone is not administered in time.

DOVE was originally developed in the Brenner Bioengineering Lab, and is now part of an academic collaboration including Penn and Drexel University.  Our goal is to develop DOVE and other technologies to address the intersection of medicine and social justice.

​